Chargement en cours...
RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
The present study was designed to investigate the association between response evaluation criteria in solid tumors (RECIST) 1.1 and 1.0, and to explore the utility of thyroglobulin (Tg) measurements in assessing tumor responses to sorafenib in patients with radioactive iodine (RAI)-refractory differ...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3789091/ https://ncbi.nlm.nih.gov/pubmed/24137351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2013.1424 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|